Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

I’m Selling My The McGraw-Hill Companies, Inc. (MHP) Stake

My Special Situations portfolio had a nice run with The McGraw-Hill Companies, Inc. (NYSE:MHP) , which recently sold off its education segment. My original purchase was predicated on a spin-off or sale of that division, leaving a highly cash generative business behind. We saw that come to fruition, and a sale of the shares just a few days ago would have seen the position up nearly 20% in about nine months.

But what a difference a day makes!

Since then, the U.S. Department of Justice has announced that it is filing a civil suit against the company’s Standard & Poor’s unit. As The Wall Street Journal explained: “The Justice Department alleges that S&P knew the housing market was collapsing but was intentionally slow to downgrade hundreds of securities because of concerns that such a move would cut off the pipeline of deals and anger issuer clients.” The government has said that it could seek more than $5 billion as part of the suit. For reference, McGraw’s market cap is about $14 billion.

The McGraw-Hill Companies, Inc.It surprises no one that the stock plummeted on the news. And it won’t be surprising if further negative details emerge as the government bangs the drum. That presents a lot of headline risk for the company, something I had suspected was largely past, given the five years since the housing market exploded with not much in the way of penalties against the ratings agencies. Investors in Moody’s Corporation (NYSE:MCO) have also seen shares tank, for similar reasons, expecting that agency to be next in the firing line.

Of course, the ratings agencies aren’t the only players responsible for deep-sixing the global economy, but the big banks are too politically well-connected to receive the scrutiny and action that they deserve, and S&P’s fatuous downgrade of U.S. debt in 2011 did it no favors.

So I’m selling my McGraw-Hill shares with a modest loss (as of this writing). I bought at $48.77, and with the stock now around $45, my Special Situations portfolio will notch a loss of about 8% if we could sell today. Tomorrow, I’ll liquidate the position and return to looking for other special situations.

The article I’m Selling My McGraw-Hill Stake originally appeared on and is written by Jim Royal.

Jim Royal has no position in any stocks mentioned. The Motley Fool recommends Moody’s. The Motley Fool owns shares of McGraw-Hill.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!